Display Settings:

Format

Send to:

Choose Destination
    Rev Med Interne. 2007 Oct;28(10):677-81. Epub 2007 May 25.

    [Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival].

    [Article in French]

    Source

    Service de médecine interne, hôpital Sud, 16 boulevard de Bulgarie, BP 90347, 35203 Rennes cedex 02, France. olivier.decaux@chu-rennes.fr

    Abstract

    PURPOSE:

    Recent development of interphase fluorescence in situ hybridization (FISH) allows analysis on non-proliferant plasma cells. We describe the most frequent genetic abnormalities in multiple myeloma and their prognostic value. CURRENT KNOWLEDGE AND

    KEY POINTS:

    Most frequent genetic abnormalities are illegitimate rearrangements involving the IGH gene at 14q32 (60% of patients), hyperdiploidy (50 to 60% of patients), chromosome 13 deletion (40 to -50% of patients), chromosome 1q gain (30 to -40% of patients) chromosome 17 deletion (10% of patients). Some of these genetics abnormalities are observed in monoclonal gammopathy of undetermined significance (MGUS), a pre-malignant state. t(4;14) and t(14;16) translocations and chromosome 17 deletion negatively impact the overall survival. Patients with these genomic aberrations should be treated with specific treatment.

    FUTURE PROSPECTS AND PROJECTS:

    Identification of genetic abnormalities is important for evaluation of prognosis and treatment protocol in multiple myeloma.

    PMID:
    17559979
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk